HMOs for life: DSM-Firmenich discusses the importance and potential of HMOs for human health

21 Aug 2023 — The use of human milk oligosaccharides (HMOs) as an ingredient in baby and toddler products is seeing a remarkable increase. From 2018 to 2022, there was an annual compound growth rate of 93% in global HMO-containing launches. The majority of these launches in 2022 consisted of baby formula and milk. 

Nutrition Insight speaks with James Young, the vice president of early life nutrition at DSM-Firmenich, about the upcoming developments in the HMO space, the company’s vision for the ingredient’s future and what makes HMOs important.